Belsomra vs. Dayvigo vs. Quviviq: What the Evidence Shows

Belsomra (suvorexant), Dayvigo (lemborexant), and Quviviq (daridorexant) belong to a more recent drug class known as twin orexin receptor antagonists, or DORAs. They work in another way from Ambien and benzodiazepines. As an alternative of boosting the mind’s calming chemical GABA, they block orexin, the sign that retains you awake. Trials present all three beat placebo for falling asleep and staying asleep. In addition they carry actual unwanted effects, and meta-analyses disagree on how usually uncommon ones like sleep paralysis happen. Sleep pointers nonetheless put CBT-I first for power insomnia. A health care provider ought to resolve whether or not any of those medicine matches you. That is instructional data, not medical recommendation.

Quick reply (40-60 phrases): Belsomra, Dayvigo, and Quviviq block orexin, the mind’s wake sign. Trials present they assist individuals go to sleep and keep asleep higher than placebo. Negative effects embrace next-day drowsiness, and a few analyses hyperlink them to sleep paralysis and vivid desires. CBT-I stays the first-line remedy for power insomnia.

How Do DORAs Work?

Orexin is a mind chemical that promotes wakefulness. DORAs block the 2 orexin receptors, known as OX1R and OX2R. That lowers the drive to remain awake. Older sleep medicine, together with Ambien and benzodiazepines, calm the mind via GABA as an alternative.

As a result of they work via a distinct system, DORAs usually are not linked to physiological dependence the way in which benzodiazepines are, in response to a 2025 community meta-analysis. Within the US they’re nonetheless managed substances, so docs prescribe them with care. The FDA accepted suvorexant in 2014, lemborexant in 2019, and daridorexant in 2022.

How Effectively Do They Work?

Two massive community meta-analyses pooled randomized trials of all three medicine.

A 2025 evaluation in Translational Psychiatry lined eight trials and 5,198 adults, with a mean age of 56. It discovered average to excessive certainty proof that suvorexant at 20 and 40 mg and daridorexant at 10 and 50 mg had been the best at shortening the time to go to sleep. The authors advised lemborexant 5 mg as an inexpensive first possibility, adopted by lemborexant 10 mg or suvorexant, although the appropriate alternative is determined by your well being and your prescriber.

A 2023 evaluation in Frontiers in Pharmacology pooled 9 trials and seven,257 individuals. All three medicine beat placebo on time to go to sleep, whole sleep time, time awake after falling asleep, and the Insomnia Severity Index. Increased doses typically labored higher than decrease ones. The identical evaluation discovered suvorexant 10 mg had poor efficacy, regardless of being a labeled dose. It named suvorexant 20 mg, lemborexant 5 and 10 mg, and daridorexant 50 mg as appropriate choices.

At a Look: The Three Medication

What Are the Facet Results?

Most trial individuals tolerate DORAs, and severe adversarial occasions didn’t rise above placebo within the main analyses. Even so, unwanted effects occur. Widespread ones embrace next-day drowsiness, headache, and irregular desires. In an observational assessment of lemborexant, 94.7 p.c of sufferers reported no adversarial results, and the most typical ones had been somnolence at 5.1 p.c and nightmares at 4.9 p.c.

The proof disagrees on rarer results. A current meta-analysis reported the next threat of narcolepsy-like signs, equivalent to sleep paralysis, with FDA-approved DORAs than with placebo. Daridorexant confirmed the best total price of treatment-emergent adversarial occasions in that evaluation, and lemborexant confirmed the best price of treatment-related ones. A separate community meta-analysis discovered no vital distinction from placebo in sleep paralysis or irregular desires between any energetic drug and placebo. Researchers haven’t settled this level.

Drug labels additionally warn about next-morning impairment, so keep away from driving or working equipment till you know the way a drug impacts you. Labels additionally warn about worsening melancholy. In contrast to Z-drugs, DORAs don’t carry the FDA’s boxed warning for complicated sleep behaviors. For that comparability, learn our Ambien side effects guide.

How Do DORAs Examine With CBT-I?

CBT-I stays the first-line remedy. The American Academy of Sleep Drugs (AASM) offers CBT-I a powerful suggestion for power insomnia. A 2025 AASM-commissioned assessment discovered CBT-I alone was the best first-line possibility. Including treatment gave solely modest additional profit for a number of outcomes. See our CBT-I guide.

DORAs additionally lack robust proof in some teams. Analysis on insomnia that comes with psychiatric situations stays restricted. When you take different drugs, have melancholy or sleep apnea, or drive for work, your physician must weigh these components.

Who May Ask Their Physician A few DORA?

A DORA could come up when CBT-I has not labored, if you can not entry it, or when a physician needs a non-benzodiazepine possibility for short-term aid. Inquiries to convey to your appointment:

• Why this drug as an alternative of CBT-I or a distinct treatment?
• How lengthy ought to I take it, and the way will we assessment it?
• What are the next-day dangers for me, together with driving?
• How does it work together with my different drugs and dietary supplements?
• What’s the value, and does my insurance coverage cowl this brand-name drug?

For a plain-language overview of all classes, see our sleeping pills guide. Need to speak via your choices? Book a consultation with The Sleep Consultant. We don’t prescribe, and we are going to enable you put together questions in your physician.

What the Analysis Exhibits

DORAs beat placebo for insomnia. A 2023 community meta-analysis of 9 trials and seven,257 individuals discovered all three medicine improved time to go to sleep, whole sleep time, and insomnia severity.

Doses matter. The identical evaluation discovered suvorexant 10 mg had poor efficacy, whereas suvorexant 20 mg, lemborexant 5 and 10 mg, and daridorexant 50 mg labored effectively.

Severe adversarial occasions didn’t rise above placebo. Each main meta-analyses discovered no enhance in severe adversarial occasions, although minor results like drowsiness and irregular desires occurred.

Proof on uncommon results conflicts. One meta-analysis discovered extra narcolepsy-like signs with DORAs, whereas one other discovered no vital distinction in sleep paralysis or nightmares.

This text is for instructional functions solely and isn’t an alternative choice to personalised medical recommendation, analysis, or remedy.

If you need to see how we’d have the ability that will help you with this deeper, schedule a free consult here.

Need a Free Beginning Level?

Be a part of the free sleep course and group: Join the Sleep Nirvana Club

When to Search Skilled Assist

• You’re excited about beginning, stopping, or altering a sleep treatment
• You’re feeling groggy the morning after a dose or discover sleep paralysis or vivid hallucinations
• You’ve gotten melancholy, sleep apnea, or a historical past of substance use alongside insomnia
• Your insomnia has lasted three months or longer with no clear plan
• You drive for work or function equipment

Steadily Requested Questions

What are Belsomra, Dayvigo, and Quviviq?

They’re prescription insomnia medicine known as twin orexin receptor antagonists. Belsomra is suvorexant, Dayvigo is lemborexant, and Quviviq is daridorexant. They block orexin, the mind sign that promotes wakefulness.

Are these medicine higher than Ambien?

They work via a distinct system, and they aren’t linked to physiological dependence the way in which benzodiazepines are. Direct superiority over Ambien will not be established within the proof I reviewed. They don’t carry the FDA’s boxed warning for complicated sleep behaviors that Z-drugs carry.

What are the unwanted effects of DORAs?

Widespread results embrace next-day drowsiness, headache, and irregular desires. Some analyses hyperlink DORAs to sleep paralysis and different narcolepsy-like signs, whereas one other discovered no vital distinction from placebo. Labels additionally warn about worsening melancholy.

Ought to I take a DORA as an alternative of doing CBT-I?

Tips put CBT-I first for power insomnia. A 2025 AASM-commissioned assessment discovered CBT-I alone labored greatest, and including treatment gave solely modest additional profit. A health care provider may help you resolve if a drug is smart alongside or after CBT-I.

Is it secure to cease a DORA alone?

Speak to your prescriber earlier than you modify or cease any prescription sleep treatment. Your physician can plan the change and enable you handle how your sleep feels afterward.

When to Work With a Sleep Guide

Newer medicine add choices, however they don’t exchange a plan. If you’d like assist getting ready for a drugs dialog, or constructing habits that help your sleep, we may help.

Schedule a free sleep assessment.